Inspect
0645.950.417 · rovalta.com · 20/09/2026
Inspect
Overview
What does Inspect do?
Inspect is a Private limited company incorporated in 2016. Its main activity is: Management consultancy activities. Its registered office is in Gent.
9052 Gent · FlandreSee on map
Trend over 10 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||||||||||||
| Gross margin | 93,0 k € | -28.7% | 130,6 k € | +98.0% | 66,0 k € | +245% | 19,1 k € | +34.3% | 14,2 k € | -39.5% | 23,5 k € | +3761% | -641,5 € | -107% | 8,7 k € | +6.4% | 8,1 k € | -34.2% | 12,4 k € |
| EBITDA | 35,9 k € | -57.5% | 84,6 k € | +29.3% | 65,4 k € | +251% | 18,6 k € | +35.4% | 13,7 k € | -40.3% | 23,0 k € | +2152% | -1,1 k € | -114% | 8,0 k € | +0.2% | 8,0 k € | -35.3% | 12,4 k € |
| Operating result | 25,3 k € | -66.9% | 76,3 k € | +31.5% | 58,0 k € | +358% | 12,7 k € | +31.7% | 9,6 k € | -52.4% | 20,2 k € | +616% | -3,9 k € | -175% | 5,2 k € | -34.8% | 8,0 k € | -29.4% | 11,3 k € |
| Net result | 18,2 k € | -69.5% | 59,6 k € | +51.5% | 39,3 k € | +310% | 9,6 k € | +33.2% | 7,2 k € | -49.8% | 14,4 k € | +455% | -4,0 k € | -199% | 4,1 k € | -1.7% | 4,2 k € | -31.4% | 6,1 k € |
| Balance sheet | |||||||||||||||||||
| Equity | 135,9 k € | -4.9% | 143,0 k € | +71.5% | 83,4 k € | +75.2% | 47,6 k € | +67.0% | 28,5 k € | +2.3% | 27,9 k € | +91.2% | 14,6 k € | -21.7% | 18,6 k € | +19.4% | 15,6 k € | +27.0% | 12,3 k € |
| Total assets | 218,0 k € | -4.2% | 227,5 k € | +78.8% | 127,3 k € | +41.9% | 89,7 k € | +146% | 36,5 k € | +4.7% | 34,8 k € | +89.2% | 18,4 k € | -23.0% | 23,9 k € | +19.7% | 20,0 k € | +9.9% | 18,2 k € |
| Cash | 100,4 k € | +13.8% | 88,2 k € | +106% | 42,9 k € | +80.5% | 23,7 k € | +111% | 11,2 k € | -60.9% | 28,8 k € | +566% | 4,3 k € | -60.4% | 10,9 k € | -26.2% | 14,8 k € | +43.0% | 10,4 k € |
| Debts | 82,1 k € | +14.0% | 72,0 k € | +64.2% | 43,9 k € | +4.2% | 42,1 k € | +427% | 8,0 k € | +14.4% | 7,0 k € | +81.4% | 3,8 k € | -27.7% | 5,3 k € | +20.9% | 4,4 k € | -25.6% | 5,9 k € |
Indicative valuation
As an indication, this company is worth
Board of directors
Seen on filing of 31/12/2025 · 1 active · 1 ended
Active mandates
Ended mandates
Other companies at this address
| Company | CBE no. |
|---|---|
Amalus Therapeutics● Bankrupt | 0803.929.268 |
APCOR R&M● Active | 0600.952.909 |
Ardoyen● Active | 0875.102.821 |
AVROXA● Active | 0687.774.936 |
Benebiose● Active | 0784.521.548 |
BioNeering● Active | 0807.194.309 |
CONTREL EUROPE● Active | 0426.204.637 |
CRODEON TECHNOLOGIES● Active | 0642.754.761 |
Cryptobiotix● Active | 0762.565.104 |
Gulliver Biomed● Active | 0692.527.837 |
ImplicitMeasures.com● Bankrupt | 0657.989.701 |
Inbiose● Active | 0534.887.593 |
| 0440.054.752 | |
INNOVATIVE PHARMACEUTICS● Active | 0883.574.582 |
INVIBES ADVERTISING● Active | 0836.533.938 |
KYTOS● Active | 0768.755.286 |
Lares Solutions● Active | 1015.346.906 |
| 0755.350.975 | |
| 0742.910.132 | |
| 0667.765.816 |
Financials
Full financial information
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 16/06/2026 | 20/06/2025 | 03/07/2024 | 21/06/2023 | 17/06/2022 | 18/06/2021 |
| General meeting | 08/06/2026 | 07/06/2025 | 27/06/2024 | 07/06/2023 | 07/06/2022 | 07/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Looking for more information about this company?
Try for 7 daysAnnual accounts filings
10 filings with the NBB
| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 31/12/2025 | 08/06/2026 | 16/06/2026 | Dutch | |
| Micro model | 31/12/2024 | 07/06/2025 | 20/06/2025 | Dutch | |
| Micro model | 31/12/2023 | 27/06/2024 | 03/07/2024 | Dutch | |
| Micro model | 31/12/2022 | 07/06/2023 | 21/06/2023 | Dutch | |
| Micro model | 31/12/2021 | 07/06/2022 | 17/06/2022 | Dutch | |
| Micro model | 31/12/2020 | 07/06/2021 | 18/06/2021 | Dutch | |
| Micro model | 31/12/2019 | 08/06/2020 | 15/06/2020 | Dutch | |
| Micro model | 31/12/2018 | 07/06/2019 | 25/06/2019 | Dutch | |
| Micro model | 31/12/2017 | 07/06/2018 | 06/07/2018 | Dutch | |
| Micro model | 31/12/2016 | 07/06/2017 | 30/06/2017 | Dutch |
Valuation
Indicative valuation
As an indication, this company is worth
between 250 k€ and 500 k€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Seen on filing of 31/12/2025 · 1 active · 1 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 202518,2 k €↓
- 2024Annual accounts 202459,6 k €↑
- 2023Annual accounts 202339,3 k €↑
- 2022Annual accounts 20229,6 k €↑
- 2021Annual accounts 20217,2 k €↓
- 2020Annual accounts 202014,4 k €↑
- 2019Annual accounts 2019-4,0 k €↓
- 2018Annual accounts 20184,1 k €↓
- 2017Annual accounts 20174,2 k €↓
- 2016Annual accounts 20166,1 k €
- 14/01/2016IncorporationPrivate limited company